Directory
Portfolio companies.
21,000+ PE-backed.
Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.
Active deals
919
currently held
Exits tracked
338
hand-checked
Sectors covered
1
across the portfolio
Countries covered
35
from every market
1,150 companies matching · Page 3 of 23
Groupe Grimaud
Crédit Mutuel Equity
FranceSector
Biotech
InvestorCrédit Mutuel Equity
Entry
2005
Hold
10yr
Owners
2
Exit
2021
Polygon
Sorbonne Venture
FranceSector
Biotech
InvestorAloe Private Equity
Entry
2010
Hold
11yr
Owners
2
Sirion
Brookfield Growth Fund
USASector
Biotech
InvestorBrookfield Asset Management
Entry
2006
Hold
15yr
Owners
2
eFFECTOR Therapeutics
Abingworth Bioventures VI
USSector
Biotech
InvestorAbingworth
Entry
2013
Hold
8yr
Exit
2021
Gyroscope Therapeutics
CIC Fund I
UKSector
Biotech
InvestorCambridge Innovation Capital
Entry
2019
Hold
2yr
Exit
2021
LAVA Therapeutics
Ysios BioFund III
NL
Sector
Biotech
InvestorYsios Capital Partners
Entry
2020
Hold
1yr
Exit
2021
PegaOne
BioDiscovery 5
FranceSector
Biotech
InvestorAndera Partners
Entry
2019
Hold
2yr
Exit
2021
Viralgen Commercial
Columbus Life Science Fund II
SpainSector
Biotech
InvestorColumbus Venture Partners
Entry
2019
Hold
2yr
Exit
2021
BioAgilytix
Cinven Seventh Fund
UKSector
Biotech
InvestorCinven
Entry
2018
Hold
8yr
Owners
4
Sanifit Therapeutics
Alta Life Sciences Spain I FCR
SpainSector
Biotech
InvestorAlta Life Sciences
Entry
2006
Hold
15yr
Owners
4
Exit
2021
Aura Biosciences
Columbus Innvierte Life Science Fund I
USSector
Biotech
InvestorColumbus Venture Partners
Entry
2015
Hold
6yr
Owners
3
Exit
2021
JeNaCell
Evonik Venture Capital
GermanySector
Biotech
InvestorEvonik Venture Capital
Entry
2012
Hold
9yr
Owners
3
Exit
2021
Sirion Biotech
Creathor Venture Fund II
GermanySector
Biotech
InvestorCreathor Ventures
Entry
2007
Hold
14yr
Owners
3
Exit
2021
Biosergen
Karolinska Development
SwedenSector
Biotech
InvestorKarolinska Development
Entry
2004
Hold
22yr
Owners
2
Cube Biotech
MED III
GermanySector
Biotech
InvestorARCHIMED
Entry
2012
Hold
9yr
Owners
2
evitria
AFINUM VIII Buyout (2017)
SwitzerlandSector
Biotech
InvestorAFINUM Management GmbH
Entry
2018
Hold
3yr
Owners
2
Exit
2021
Sanifit
Ysios BioFund I
SpainSector
Biotech
InvestorYsios Capital Partners
Entry
2015
Hold
6yr
Owners
2
Exit
2021
Abexxa Biologics
Boehringer Ingelheim Venture Fund
USSector
Biotech
InvestorBoehringer Ingelheim Venture Fund
Entry
2016
Hold
5yr
Exit
2021
ALRISE Biosystems
VC Fonds Technologie Berlin
GermanySector
Biotech
InvestorIBB Ventures
Entry
2006
Hold
15yr
Exit
2021
Amplyx Pharmaceuticals
Lundbeckfonden BioCapital
United StatesSector
Biotech
InvestorLundbeckfonden BioCapital
Entry
2017
Hold
4yr
Exit
2021
aquila biolabs
Seed Fonds Aachen
GermanySector
Biotech
InvestorS-UBG AG Aachen Krefeld Mönchengladbach
Entry
2015
Hold
6yr
Exit
2021
Arvelle
BioDiscovery 5
SwitzerlandSector
Biotech
InvestorAndera Partners
Entry
2019
Hold
2yr
Exit
2021
BioCity Group
BGF
UKSector
Biotech
InvestorBGF
Entry
2019
Hold
2yr
Exit
2021
Century Therapeutics
Leaps by Bayer
United StatesSector
Biotech
InvestorLeaps by Bayer
Entry
2019
Hold
2yr
Exit
2021
Eliem Therapeutics
LifeArc Ventures
United StatesSector
Biotech
InvestorLifeArc
Entry
2021
Hold
0yr
Exit
2021
Forendo Pharma
Sunstone Life Science Ventures IV
FinlandSector
Biotech
InvestorSunstone Life Science Ventures
Entry
2019
Hold
2yr
Exit
2021
GAMUT Therapeutics
AFB Seed-Fund
FranceSector
Biotech
InvestorAdBio Partners
Entry
2020
Hold
1yr
Exit
2021
HyTest
Summa Equity Fund I
FinlandSector
Biotech
InvestorSumma Equity
Entry
2018
Hold
3yr
Exit
2021
Lipigon
Almi Invest (Regional funds)
SwedenSector
Biotech
InvestorAlmi Invest
Entry
2016
Hold
5yr
Exit
2021
lophius
S-Refit AG
GermanySector
Biotech
InvestorSobera Capital
Entry
2016
Hold
5yr
Exit
2021
MedDay Pharmaceuticals
BioDiscovery 4
FranceSector
Biotech
InvestorAndera Partners
Entry
2016
Hold
5yr
Exit
2021
Metabogen
GU Ventures Evergreen
SwedenSector
Biotech
InvestorGU Ventures
Entry
2011
Hold
10yr
Exit
2021
Olink Proteomics
Summa Equity Fund II
SwedenSector
Biotech
InvestorSumma Equity
Entry
2019
Hold
2yr
Exit
2021
Origo Biopharma
Sabadell Asabys Health Innovation Investments
SpainSector
Biotech
InvestorAsabys Partners
Entry
2020
Hold
1yr
Exit
2021
OXGENE
Mercia Direct Investments
UKSector
Biotech
InvestorMercia Asset Management
Entry
2015
Hold
6yr
Exit
2021
Philogen
The Equity Club
ItalySector
Biotech
InvestorThe Equity Club
Entry
2019
Hold
2yr
Exit
2021
Protagen Protein Services (PPS)
ZFHN Zukunftsfonds Heilbronn (D11Z. Ventures Evergreen)
GermanySector
Biotech
InvestorD11Z. Ventures
Entry
2012
Hold
9yr
Exit
2021
Recursion Pharmaceuticals
Leaps by Bayer
United StatesSector
Biotech
InvestorLeaps by Bayer
Entry
2020
Hold
1yr
Exit
2021
Vaccitech
Oxford Science Enterprises Balance Sheet
UKSector
Biotech
InvestorOxford Science Enterprises
Entry
2016
Hold
5yr
Exit
2021
Vera Therapeutics
Abingworth Bioventures 8
USSector
Biotech
InvestorAbingworth
Entry
2021
Hold
0yr
Exit
2021
Immatics
Athos Evergreen Life Sciences
GermanySector
Biotech
InvestorAthos
Entry
2004
Hold
20yr
Owners
5
AskBio
Columbus Innvierte Life Science Fund I
United StatesSector
Biotech
InvestorColumbus Venture Partners
Entry
2016
Hold
4yr
Exit
2020
Compass Pathways
Principia III - Health
United KingdomSector
Biotech
InvestorPrincipia SGR
Entry
2018
Hold
2yr
Exit
2020
Integragen
FPCI Entreprise & Croissance I
FranceSector
Biotech
InvestorGeneris Capital Partners
Entry
2010
Hold
10yr
Exit
2020
Spruce Biosciences
Abingworth Bioventures VII
USSector
Biotech
InvestorAbingworth
Entry
2020
Hold
0yr
Exit
2020
The Native Antigen Company
Mercia Direct Investments
UKSector
Biotech
InvestorMercia Asset Management
Entry
2014
Hold
6yr
Exit
2020
m2p-labs
FIDURA Rendite Sicherheit Plus Ethik 3
GermanySector
Biotech
InvestorFIDURA Private Equity Fonds
Entry
2006
Hold
14yr
Owners
3
Exit
2020
ChromoTek
HTGF I
GermanySector
Biotech
InvestorHigh-Tech Gruenderfonds (HTGF)
Entry
2010
Hold
10yr
Owners
2
Exit
2020
Corvidia Therapeutics
BioDiscovery 5
United StatesSector
Biotech
InvestorAndera Partners
Entry
2016
Hold
4yr
Owners
2
Exit
2020
Galecto Biotech
Quadrivium 1 Seed Fund
DenmarkSector
Biotech
InvestorSeventure Partners
Entry
2018
Hold
8yr
Owners
2